文献速递血液透析通路

肱动脉-贵要静脉动静脉瘘浅表化技术的一年期功能通畅率比较

One-Year Functional Patency and Comparison of Superficialization Techniques for Brachiobasilic Arteriovenous Fistulas.
PubMed 文献 · Ann Vasc Surg · 2025-05-29

这项多机构回顾性研究纳入2014至2019年间接受两阶段肱动脉-贵要静脉动静脉瘘(BBAVF)且随访至少1年的260例患者,评估浅表化技术及其他变量对12个月功能通畅率的影响。总体12个月功能通畅率为71.5%;第一阶段使用阿司匹林和术中抗凝与较高功能通畅率相关,而既往动静脉瘘或移植物与较低功能通畅率相关。比较架桥法与转位法,功能通畅率无显著差异(83.6% vs. 89.9%,P=0.179),但架桥法术后并发症发生率更高(19.8% vs. 9.0%,P=0.027)。

要点

  • 两阶段BBAVF总体12个月功能通畅率为71.5%。
  • 第一阶段使用阿司匹林和术中抗凝与12个月功能通畅率较高相关。
  • 架桥法与转位法功能通畅率无显著差异,但架桥法术后并发症更多。

核心结论

  • 在两阶段BBAVF患者中,第一阶段使用阿司匹林和术中肝素与12个月功能通畅率较高相关。
  • 第二阶段架桥法与转位法的功能通畅率相似,但架桥法术后并发症发生率更高,主要与伤口愈合相关。

研究设计与样本

  • 多机构回顾性研究,纳入5家安全性网医院2014至2019年间接受两阶段BBAVF且随访至少1年的260例患者。
  • 主要终点为12个月功能通畅率,采用双变量和多变量逻辑回归模型评估术前和术中变量与12个月瘘管功能的关系。

主要发现

  • 总体12个月功能通畅率为71.5%。
  • 第一阶段使用阿司匹林与12个月功能通畅率相关(OR 1.858,95%CI 1.023-3.372,P=0.042)。
  • 第一阶段术中抗凝与12个月功能通畅率相关(OR 2.118,95%CI 1.193-3.760,P=0.01)。
  • 既往动静脉瘘或移植物与12个月功能通畅率相关(OR 0.465,95%CI 0.233-0.928,P=0.030)。
  • 架桥法与转位法功能通畅率无显著差异(83.6% vs. 89.9%,P=0.179),但架桥法术后并发症发生率更高(19.8% vs. 9.0%,P=0.027)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Superficialization of brachiobasilic arteriovenous fistulae (BBAVFs) is generally performed by either creating a shelf or dividing, tunneling, and transposing the vein with reanastomosis. This multiinstitutional study evaluates the impact of these techniques and other variables on BBAVF functional patency at 12 months. METHODS: A retrospective review of patients who underwent two-stage BBAVF between 2014 and 2019 with at least 1-year follow-up was conducted from 5 safety net hospitals. The primary end point was functional patency at 12 months. Bivariate and multivariate logistic regression models evaluated the relationship between preoperative and intraoperative variables and fistula function at 12 months. RESULTS: There were 260 patients with an overall 12-month functional patency rate of 71.5%. Use of aspirin (odds ratio [OR] 1.858, 95% confidence interval [CI] 1.023-3.372, P = 0.042) and intraoperative anticoagulation (OR 2.118, 95% CI 1.193-3.760, P = 0.01) at the first stage procedure, and previous arteriovenous fistula or graft (OR 0.465, 95% CI 0.233-0.928, P = 0.030), were associated with functional patency at 12 months. When comparing shelfing versus transposition techniques, there was no significant difference in the functional patency rates (83.6% vs. 89.9%, P = 0.179), although the shelfing technique was associated with a higher rate of postoperative complications (19.8% vs. 9.0%, P = 0.027). CONCLUSION: In patients undergoing 2-stage BBAVF, the use of aspirin and intraoperative heparin at the first stage procedure are associated with higher functional patency at 12 months. Functional patency was similar for the shelfing technique versus transposition at the second stage. The shelfing technique was associated with higher rates of postoperative complications, primarily related to wound healing.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hurwitz M, de Virgilio C, Ugarte R, et al. One-Year Functional Patency and Comparison of Superficialization Techniques for Brachiobasilic Arteriovenous Fistulas. Ann Vasc Surg. 2025. PMID: 40447037. doi:10.1016/j.avsg.2025.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。